// App-Quantinova.ai

: A systematic literature review to evaluate extended dosing intervals in the pharmacological management of acromegaly

Researchers

Presenter

  • Maria Fleseriu

Principal Investigators

  • Zhaoyun Zhang

  • Kate Hanman

  • Keval Haria

  • Aude Houchard

  • Sheila Khawaja

  • Antonio Ribeiro-Oliveira

  • Monica Gadelha

Medical Centers

  • Parkinson Center Oregon Health & Science University Portland OR United States

  • Fudan University, Shanghai, China

  • Costello Medical, London, United Kingdom

  • Ipsen, Boulogne-Billancourt, France

  • World Alliance of Pituitary Organizations, Zeeland, Netherlands

  • Biogen, Cambridge, United States

  • Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil

Locations

  • United States

  • China

  • United Kingdom

  • France

  • Netherlands

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acromegaly

Biomarkers

  • N/A

Drug/Treatment

  • octreotide long-acting release

  • Lanreotide

  • Oral octreotide

  • Cabergoline

  • Pasireotide

  • Pegvisomant

  • Octreotide

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved